风靡互联网的全景相机，上市了。 6月11日，影石创新（688775.SH，下文简称"影石"）在上交所科创板成功上市。公司上市首日较开盘价47.27元高开285.02%报182元/股，总市值约730亿 元。 这头独角兽自2020年启动IPO起，历时5年，终于得偿所愿。 正如刘靖康过去曾表示，影石Insta360的发展离不开政府的政策扶持，也和深圳的人才优势、产业集聚、开放文化等大环境息息相关，"非常感谢深圳市政 府一直以来给我们的鼓励和支持。未来我们将继续以'帮助人们更好地记录和分享生活'为使命，以新影像行业为基石，矢志创新、不断突破，围绕'成为世 界一流的智能影像品牌'的愿景而奋发努力。" 90后技术大咖，收获一个百亿IPO 执掌这个百亿IPO的90后刘靖康，也顺理成章拿下人生第一个IPO。 这是一位极具传奇色彩的"90后"创业者。出生于广东中山的刘靖康，自小便对电脑技术充满兴趣。高中时期，他凭借出色的技术能力在全国中小学生电脑 制作大赛中获奖，后来高考也顺利进入南京大学软件学院就读软件工程专业。 大学期间，刘靖康便以一系列大胆而富有创意的技术"整活"成为校园风云人物，是早期"校园极客"一员，同时也是小有名气 ...

Core Insights - The stock of Jiaoda Iron and Steel (920027) surged by 262.09% on its debut, with a turnover rate of 72.03% and a transaction volume of 621 million yuan [2] - The stock's first-day margin trading saw a buy amount of 5.25 million yuan, accounting for 0.85% of the total trading volume, with a current margin balance of 4.35 million yuan, representing 0.52% of the circulating market value [2] Company Overview - Jiaoda Iron and Steel specializes in the research, development, production, and sales of intelligent products and equipment for rail transit, along with providing professional technical services [2] Recent IPO Performance - The first-day performance of newly listed stocks shows significant variations, with Jiaoda Iron and Steel leading with a 262.09% increase, while other recent IPOs like C Zhongce (603049) and C Youyou (301590) had increases of 6.84% and 68.64% respectively [2][3] - The margin trading details of other recent IPOs indicate varying levels of investor interest, with C Zhongce having a margin balance of 134.77 million yuan, representing 3.20% of its circulating market value [3]

Group 1 - Kaichun Co., Ltd. adjusted the share repurchase price limit from 26.625 yuan/share to 40 yuan/share, effective from June 10, 2025 [1] - Yipin Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, a Class 3 chemical drug used for sedation during anesthesia [1] - Bohui Innovation obtained a medical device registration certificate for HPV Genotyping Test Kit, used for qualitative detection of HPV DNA [1][2] Group 2 - Lingyi Zhi Zao's application for issuing convertible bonds and cash payment to acquire 66.46% of Jiangsu Kedasiteng Automotive Technology Co., Ltd. has been accepted by the Shenzhen Stock Exchange [3] - Kemin Food reported a 23.06% year-on-year increase in pig sales in May, with a total of 48,300 pigs sold [4][5] - Meian Sen decided to terminate the issuance of shares to specific objects due to market conditions and strategic considerations [6][7] Group 3 - Zhengbang Technology reported a 146.6% year-on-year increase in pig sales revenue in May, totaling 731 million yuan [9] - Yuanda Holdings plans to reduce the registered capital of its subsidiary from 73 million to 24.3 million USD to optimize asset structure [10] - East China Pharmaceutical's subsidiary received FDA approval for clinical trials of HDM1010 tablets for type 2 diabetes [12] Group 4 - Liangxin Co., Ltd. received a government subsidy of 14.1 million yuan, accounting for 4.52% of its audited net profit for 2024 [13] - Erkang Pharmaceutical's Vitamin B6 Injection passed the consistency evaluation for generic drugs [14] - New Industry received a patent certificate for an antibody related to anti-PIC detection, enhancing detection efficiency [16][15] Group 5 - Dongxing Medical signed a 6 million yuan technology development contract with Shanghai Jiao Tong University for collagen preparation processes [16] - Suchang Chai A's subsidiary will absorb and merge another subsidiary, adjusting internal equity structure [17] - Yibin Technology received a project designation notice from a domestic new energy vehicle company, with an estimated total sales of 256 million yuan over five years [18] Group 6 - Mingchen Health received a cash dividend of 20 million yuan from its subsidiary [19] - Hendi Pharmaceutical obtained a drug registration certificate for Ibuprofen Suspension, a common medication for children [19] - Huaren Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, classified as a Category B drug under national medical insurance [20] Group 7 - Enwei Pharmaceutical obtained a renewed drug production license for six key products [21] - Xiaoming Co., Ltd. reported a 45.59% year-on-year increase in chicken product sales in May, totaling 23.25 million birds [23][24] - Shan Natural Gas successfully issued a 350 million yuan short-term financing bond with a 1.78% interest rate [25] Group 8 - Xidamen announced plans for board members to reduce their holdings by up to 581,000 shares [26] - Shentong Technology's shareholder plans to reduce holdings by up to 3% of the company's shares [27] - Saintno Bio plans to distribute a cash dividend of 0.14 yuan per share and a capital increase of 0.4 shares per share [28] Group 9 - *ST King Kong's subsidiary received a debt transfer notice from its controlling shareholder, totaling 364 million yuan [29] - Foxit Software's executives plan to reduce their holdings by a total of 55,800 shares [30] - Youyou Green Energy plans to apply for a bank credit line of up to 1.5 billion yuan [31] Group 10 - Guoxing Optoelectronics plans to distribute a cash dividend of 0.5 yuan per 10 shares [32] - Guangxun Technology plans to distribute a cash dividend of 2.6 yuan per 10 shares [33] - Hanrui Cobalt plans to distribute a cash dividend of 1.5 yuan per 10 shares [35] Group 11 - Tigermed plans to distribute a cash dividend of 3 yuan per 10 shares [37] - Shenliang Holdings plans to distribute a cash dividend of 1.5 yuan per 10 shares [38] - Yishitong plans to distribute a cash dividend of 1 yuan per 10 shares [39]

证券研究报告 2025 年 6 月 9 日 星期一 【新股发行跟踪（20250609）】 一、上周新股表现情况 上周（6 月 2 日-6 月 6 日）共有 2 只新股上市，上市首日涨跌幅均值 为 37.74%。其中，无新股上市首日涨幅超 100%。上周无新股首日破发。 资料来源：东莞证券研究所，iFinD 二、周度新股上市情况走势 从周度新股上市规模来看，上周（6 月 2 日-6 月 6 日，下同）较上上 周（5 月 26 日-5 月 30 日，下同）相比，上市新股数量多 1 只，首发募资 金额多 44.03 亿元。 从周度上市新股表现来看，上周与上上周均无新股首日破发，与上上 周相比，上周首日涨幅超 100%的新股数量有所减少，上市首日涨跌幅均 值大幅下降。 资料来源：东莞证券研究所，iFinD 本报告的风险等级为中高风险。 本报告的信息均来自已公开信息，关于信息的准确性与完整性，建议投资者谨慎判断，据此入市，风险自担。请务必阅读 末页声明。 1 表 1：上周新股表现 股票代码 股票简称 上市日期 上市 板块 发行价 格（元） 发行市 盈率 证监会行业 首日收盘 涨跌幅(%) 603049.SH 中策橡胶 ...

Market Overview - As of June 9, the Shanghai Composite Index closed at 3399.77 points, up 14.41 points, with a gain of 0.43% [1] - The Shenzhen Component Index closed at 10250.14 points, up 66.44 points, with a gain of 0.65% [1] - The ChiNext Index closed at 2061.29 points, up 21.86 points, with a gain of 1.07% [1] High Turnover Stocks - A total of 96 A-shares had a turnover rate exceeding 20% on June 9 [1] - Notable stocks with high turnover rates include: - Yuyin Co., Ltd. (002177) with a turnover rate of 60.26% and a closing price of 8.22 yuan, up 4.71% [1] - Kangliyuan (301287) with a turnover rate of 59.52% and a closing price of 48.60 yuan, up 20.00% [1] - Huamai Technology (603042) with a turnover rate of 53.49% and a closing price of 19.50 yuan, up 4.45% [1] - C Youyou (301590) with a turnover rate of 50.82% and a closing price of 157.50 yuan, down 0.15% [1] Additional High Turnover Stocks - Other notable stocks with significant turnover rates include: - Jinling Sports (300651) with a turnover rate of 48.70% and a closing price of 36.90 yuan, up 15.31% [1] - Zhongke Magnetic (301141) with a turnover rate of 47.23% and a closing price of 45.85 yuan, up 13.49% [1] - Hengbao Co., Ltd. (002104) with a turnover rate of 47.18% and a closing price of 12.12 yuan, up 9.98% [1] - New World (301277) with a turnover rate of 46.80% and a closing price of 17.70 yuan, up 4.00% [1] Summary of Turnover Rates - The report includes a detailed list of stocks with their respective turnover rates, closing prices, and percentage changes, indicating active trading and potential investor interest in these companies [1][2][3][4]

IPO Review and Registration Progress - Three IPO applications were accepted last week, including Senhe High-Tech aiming for the Beijing Stock Exchange to raise 490 million yuan, Yisiwei targeting the Sci-Tech Innovation Board with a planned raise of 1.214 billion yuan, and Zhixin Co. applying for an IPO on the Shanghai Main Board with a target of 1.329 billion yuan [2][3] - Senhe High-Tech specializes in the R&D, production, and sales of environmentally friendly precious metal mining agents, with sales revenue from these agents accounting for over 95% of its main business income during the reporting period [2] - Yisiwei focuses on automotive manufacturing machine vision equipment, holding the largest market shares in China’s automotive manufacturing and complete vehicle manufacturing machine vision markets at 13.7% and 22.5% respectively [3] - Zhixin Co. develops and produces automotive welding parts and related molds, with over 70% of its revenue coming from its top five customers [3] Recent IPO Approvals and Upcoming Listings - Huaxin Precision passed its IPO review on June 6, focusing on precision stamping products, with a projected revenue of 1.421 billion yuan in 2024, a 19.49% increase year-on-year [4] - Three companies are set to undergo IPO reviews this week, including Sanxie Electric, which reported steady revenue growth from 287 million yuan in 2022 to 420 million yuan in 2024 [4][5] - United Power, a subsidiary of Huichuan Technology, achieved a revenue of 16.178 billion yuan in 2024, a 72.74% increase, with over 85% of its revenue derived from electric drive systems [5] - Daoshengtianhe, a wind power industry chain company, reported a revenue of 3.238 billion yuan in 2024, a slight increase of 1.13% [6] New Stock Listings and Subscription Dynamics - Two new stocks were listed last week, Zhongce Rubber and Youyou Green Energy, with the latter seeing a significant first-day increase of 68.64% [9][10] - This week, Jiao Da Tie Fa is scheduled to be listed on June 10, with a projected revenue of 335 million yuan in 2024 [10] - Two new stocks are set for subscription this week, including Huazhi Jie and New Henghui, with planned fundraising of approximately 486 million yuan and 519 million yuan respectively [11] Policy and Regulatory Developments - The China Securities Regulatory Commission (CSRC) announced plans to support high-quality unprofitable technology companies in going public, emphasizing the importance of information disclosure and market intermediary verification [12] - The China Listed Companies Association released guidelines for audit committees to enhance compliance and governance among listed companies [13]

民生证券股份有限公司 关于深圳市优优绿能股份有限公司 预计 2025 年度日常关联交易的核查意见 民生证券股份有限公司（以下简称"民生证券""保荐机构"）作为深圳市优 优绿能股份有限公司（以下简称"优优绿能""公司"）首次公开发行股票并在创 业板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证券交易所 上市公司自律监管指引第2号——创业板上市公司规范运作》以及《深圳证券交易 所上市公司自律监管指引第13号——保荐业务》等有关法律法规和规范性文件的要 求，对优优绿能2025年度日常关联交易预计事项进行了审慎核查，并发表如下意 见： （一）日常关联交易概述 ABB E-mobility AG系公司持股5%以上股东，ABB Ltd为间接持有公司5%以上的 股东，由于ABB Ltd控制的部分企业与公司存在交易，根据实质重于形式的原则将 ABB Ltd及其控制的公司作为公司的关联方。公司2025年度预计将与ABB Ltd及其控 制公司之间商品交易总金额不超过人民币15,000万元，公司与ABB Ltd及其控制公 司关联交易的主要内容为向关联方销售公司生产的充电模块，具体交易金额及内容 以实际签订的合同为准。 ...

证券代码：301590 证券简称：优优绿能 公告编号：2025-002 深圳市优优绿能股份有限公司 关于聘请2025年度审计机构的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示：公司本次续聘会计师事务所符合中华人民共和国财政部、国务 院国有资产监督管理委员会、中国证券监督管理委员会印发的《国有企业、上 市公司选聘会计师事务所管理办法》（财会〔2023〕4号）的规定。 深圳市优优绿能股份有限公司（以下简称"公司"）于2025年5月26日召开 第一届董事会第二十二次会议和第一届监事会第二十一会议，审议通过了《关 于聘请2025年度审计机构的议案》，同意公司续聘致同会计师事务所（特殊普 通合伙）（以下简称"致同所"）担任公司2025年度财务报告及内部控制的审 计机构，并提请股东大会授权董事会根据审计工作的业务规模、业务复杂度及 市场的普遍情况确定致同所2025年度的财务会计及内部控制审计费用。现将有 关事项公告如下： 一、拟聘会计师事务所事项的情况说明 致同所是一家具有证券、期货相关业务资格的会计师事务所，具备为上市 公司提供审计服务的经验和专业能力。该 ...

1、公司遵循的法律、行政法规、政策及经济环境不发生重大变化； 2、公司所处行业形势、市场环境、主要产品和原材料的市场价格和供求关 系不发生重大变化； 深圳市优优绿能股份有限公司 2025年度财务预算及经营战略报告 特别提示： 本报告不代表深圳市优优绿能股份有限公司（以下简称"公司"）对2025年 度的盈利预测，亦不构成公司对投资者的实质性业绩承诺，预算目标能否实现受 宏观经济、市场需求变化等多种因素，存在不确定性，敬请投资者注意投资风险。 一、预算编制说明 围绕公司战略目标及2025年度经营计划，结合宏观经济环境、市场竞争状 况、公司经营管理能力等因素，以经审计的2024年度经营业绩为基础，按照合 并报表口径，经公司审慎分析研究，编制了公司2025年度财务预算及经营战略 报告。 二、预算编制基本假设 第 1 页 扩张及客户结构多元化，同步推进降本增效、质量提升、研发攻坚及股权激励， 实现企业健康发展，致力于在激烈的市场竞争中实现质的飞跃和量的增长，力争 完成2025年预算目标。 深圳市优优绿能股份有限公司董事会 2025年6月9日 3、公司经营业务所涉及的国家或地区的社会经济环境无重大改变； 4、国家现行主要 ...

深圳市优优绿能股份有限公司 2024年度财务决算报告 深圳市优优绿能股份有限公司（以下简称"公司"）2024年12月31日合并及 母公司资产负债表、2024年度合并及母公司利润表、2024年度合并及母公司现金 流量表、2024年度合并及母公司所有者权益变动表及相关报表附注已经致同会计 师事务所（特殊普通合伙）审计并出具了标准无保留意见的审计报告，现将公司 主要财务数据报告如下： 一、2024年度主要财务数据和指标 （一）主要资产负债项目及其变动情况 | 单位：人民币万元 | | --- | | 项目 | 2024 年 12 月 31 日 | 2023 年 12 月 31 日 | 增减变动 | | --- | --- | --- | --- | | 货币资金 | 71,345.76 | 63,317.12 | 12.68% | | 应收票据 | 10,006.16 | 6,909.96 | 44.81% | | 应收账款 | 64,755.79 | 43,774.32 | 47.93% | | 应收款项融资 | 1,719.25 | 681.13 | 152.41% | | 存货 | 20,823.14 | 1 ...